Ventavis and Paroxetine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ventavis (iloprost) and Paroxetine (paroxetine hydrochloride). Common drug interactions include cardiac failure congestive among females and disease progression among males.
The phase IV clinical study analyzes what interactions people have when they take Ventavis and Paroxetine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Ventavis?
Ventavis has active ingredients of iloprost. eHealthMe is studying from 11,982 Ventavis users. Check the latest studies of Ventavis.
What is Paroxetine?
Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 65,088 Paroxetine users. Check the latest studies of Paroxetine.
11 people who take Ventavis and Paroxetine together, and have interactions are studied.

What are the common drug interactions of Ventavis and Paroxetine, by gender? *:
female:
- Cardiac failure congestive
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Cardiac failure
- Cellulitis (infection under the skin)
- Fatigue (feeling of tiredness)
- Haematoma (collection of blood outside the blood vessels)
- Peripheral swelling
- Pneumonia
- Productive cough
- Renal failure (kidney dysfunction)
male:
- Disease progression
- Drug ineffective
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Pulmonary embolism (blockage of the main artery of the lung)
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the common drug interactions of Ventavis and Paroxetine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Death
- Hyperthermia (body temperature greatly above normal)
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
50-59:
- Acute respiratory failure
- Dyspnoea (difficult or laboured respiration)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Bradycardia (abnormally slow heart action)
- Cardiac failure congestive
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Oedema (fluid collection in tissue)
- Cellulitis (infection under the skin)
- Fatigue (feeling of tiredness)
- Cardiac failure
60+:
- Cardiac arrest
- Cardiac failure
- Neuromyopathy (disease of both muscles and nerves)
- Oedema (fluid collection in tissue)
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Pulse absent
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sudden death
- Cardiomyopathy (weakening of the heart muscle)
- Disease progression
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 63.64%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 27.27%
- Essential Hypertension (primary hypertension): 1 person, 9.09%
- Depression: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Ventavis and Paroxetine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ventavis (11,982 reports)
- Paroxetine (65,088 reports)
Browse all drug interactions of Ventavis and Paroxetine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ventavis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Paroxetine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ventavis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Paroxetine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on iloprost and paroxetine hydrochloride (the active ingredients of Ventavis and Paroxetine, respectively), and Ventavis and Paroxetine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Klonopin and Advair Diskus 100/50 - 23 seconds ago
- Drug interactions of Acetaminophen and Caprylic Acid - 41 seconds ago
- Drug interactions of Celexa and Ajovy - 59 seconds ago
- Could Ambisome cause Meningitis? - a minute ago
- Could Miacalcin cause High Blood Pressure? - a minute ago
- Could Ativan cause Cerebral Disorder? - a minute ago
- Drug interactions of Cellcept and Soma - a minute ago
- Drug interactions of Fentanyl and Olive - a minute ago
- Drug interactions of Provera and Lovaza - a minute ago
- Could Lithium Carbonate cause Intestinal Obstruction? - a minute ago